OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...
These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...
Amjad Masad announced that Replit has raised $400 million in a Series D, and also unveiled a powerful new agent.
In this tutorial, we build an end-to-end cognitive complexity analysis workflow using complexipy. We start by measuring complexity directly from raw code strings, then scale the same analysis to ...
Replimune Group beat estimated earnings by 7.000000000000001%, reporting an EPS of $-0.77 versus an estimate of $-0.83. Revenue was down $0 from the same period last year. The company missed on EPS by ...
A new year brings both fresh and long-standing cyber challenges. The following innovative projects that CISOs are undertaking this year might be worth adding to your own 2026 planning list. As 2026 ...
You might be wondering just how useful a 3D printer actually is if you don't own one yet. You may ask yourself if you'll make enough things with it to make it worthwhile. Coming from a household that ...
When you get a 3D printer, it can be overwhelming to figure out what you want to make. There are several designs you can discover online, and eventually, you can create your own using programs like ...
As the year culminates, it's once again time for the ArchDaily team of curators to reflect on the best-performing projects of 2025 and consider what readers were most interested in. Through this ...
We may receive a commission on purchases made from links. When it comes to DIY tech, the Raspberry Pi is one of the most recognizable products out there. It's been around for more than a decade now, ...
The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...